Agnieszka Sobierajska-Rek

Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial

Riccardo Masson, Maria Mazurkiewicz-Bełdzińska, Kristy Rose et al. · The Lancet Neurology · 2022 · 96 citations · Full text

Type 1, Firefish Part 2, Rehabilitation +6

Establishing a telerehabilitation program for patients with Duchenne muscular dystrophy in the COVID-19 pandemic

Agnieszka Sobierajska-Rek, Łukasz Mański, Joanna Jabłońska-Brudło et al. · Wiener klinische Wochenschrift · 2020 · 53 citations · Full text

Transition from Childhood to Adulthood in Patients with Duchenne Muscular Dystrophy

Eliza Wasilewska, Sylwia Małgorzewicz, Agnieszka Sobierajska-Rek et al. · Medicina · 2020 · 41 citations · Full text

Dysmenorrhea and Associated Factors among Polish Women: A Cross-Sectional Study

Zofia Barcikowska, Karolina Wójcik-Bilkiewicz, Agnieszka Sobierajska-Rek et al. · Pain Research and Management · 2020 · 39 citations · Full text

Arthrogryposis in infancy, multidisciplinary approach: case report

Anna Binkiewicz-Glińska, Agnieszka Sobierajska-Rek, Jolanta Wierzba et al. · BMC Pediatrics · 2013 · 29 citations · Full text